Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Ann Rheum Dis
.
2021 Jun;80(6):e89.
doi: 10.1136/annrheumdis-2020-218343.
Epub 2020 Aug 7.
Authors
Augustin Lecler
1
,
Delphine Villeneuve
2
,
Catherine Vignal
3
,
Thomas Sené
2
Affiliations
1
Neuroradiology, The Fondation Adolphe de Rothschild Hospital, Paris, France alecler@for.paris.
2
Internal Medicine, The Fondation Adolphe de Rothschild Hospital, Paris, France.
3
Ophthalmology, The Fondation Adolphe de Rothschild Hospital, Paris, France.
PMID:
32769152
DOI:
10.1136/annrheumdis-2020-218343
No abstract available
Keywords:
giant cell arteritis; glucocorticoids; health services research.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Giant Cell Arteritis* / epidemiology
Glucocorticoids
Humans
Incidence
Pandemics
Substances
Glucocorticoids